XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.21.2

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
Segment Information |
Schedule of segment information - net sales and operating earnings | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Net Sales to External Customers | ​ | Operating Earnings
​ | ​ | Three Months | ​ | Six Months | ​ | Three Months | ​ | Six Months
​ | ​ | Ended June 30 | ​ | Ended June 30 | ​ | Ended June 30 | ​ | Ended June 30
(in millions) |  | 2021 |  | 2020 |  | 2021 |  | 2020 |  | 2021 |  | 2020 |  | 2021 |  | 2020
Established Pharmaceutical Products | ​ | $ | 1,180 | ​ | $ | 1,013 | ​ | $ | 2,250 | ​ | $ | 2,057 | ​ | $ | 220 | ​ | $ | 206 | ​ | $ | 389 | ​ | $ | 387
Nutritional Products | ​ |  | 2,108 | ​ |  | 1,883 | ​ |  | 4,144 | ​ |  | 3,787 | ​ |  | 490 | ​ |  | 474 | ​ |  | 957 | ​ |  | 933
Diagnostic Products | ​ |  | 3,247 | ​ |  | 1,994 | ​ |  | 7,261 | ​ |  | 3,820 | ​ |  | 1,076 | ​ |  | 522 | ​ |  | 2,777 | ​ |  | 927
Medical Devices | ​ |  | 3,666 | ​ |  | 2,423 | ​ |  | 6,986 | ​ |  | 5,360 | ​ |  | 1,208 | ​ |  | 391 | ​ |  | 2,215 | ​ |  | 1,194
Total Reportable Segments | ​ |  | 10,201 | ​ |  | 7,313 | ​ |  | 20,641 | ​ |  | 15,024 | ​ |  | 2,994 | ​ |  | 1,593 | ​ |  | 6,338 | ​ | ​ | 3,441
Other | ​ |  | 22 | ​ |  | 15 | ​ |  | 38 | ​ |  | 30 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net sales | ​ | $ | 10,223 | ​ | $ | 7,328 | ​ | $ | 20,679 | ​ | $ | 15,054 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Corporate functions and benefit plan costs | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | (132) | ​ | ​ | (106) | ​ | ​ | (246) | ​ | ​ | (238)
Net interest expense | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | (123) | ​ | ​ | (125) | ​ | ​ | (247) | ​ | ​ | (246)
Share-based compensation (a) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | (132) | ​ | ​ | (115) | ​ | ​ | (420) | ​ | ​ | (348)
Amortization of intangible assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | (504) | ​ | ​ | (553) | ​ | ​ | (1,013) | ​ | ​ | (1,114)
Other, net (b) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | (755) | ​ | ​ | (168) | ​ | ​ | (1,021) | ​ | ​ | (336)
Earnings from continuing operations before taxes | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | 1,348 | ​ | $ | 526 | ​ | $ | 3,391 | ​ | $ | 1,159
| (a) | Approximately 50 percent of the annual net cost of share-based awards will typically be recognized in the first quarter due to the timing of the granting of share-based awards.
| (b) | Other, net for the three and six months ended June 30, 2021 and 2020 includes integration costs associated with the acquisition of St. Jude Medical and Alere, and restructuring charges. 2021 restructuring charges include $499 million related to Abbott’s restructuring plan for its COVID-19 test manufacturing network. Other, net for the three and six months ended June 30, 2021 also includes costs related to certain litigation. Other, net for the three and six months ended June 30, 2020 also includes impairments of equity investments.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration